Your browser doesn't support javascript.
loading
SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015.
Aranda, E; Aparicio, J; Alonso, V; Garcia-Albeniz, X; Garcia-Alfonso, P; Salazar, R; Valladares, M; Vera, R; Vieitez, J M; Garcia-Carbonero, R.
Afiliación
  • Aranda E; Servicio de Oncología Médica. Instituto Maimónides de Investigación Biomédica (IMIBIC), Hospital Reina Sofía, Universidad de Córdoba, Córdoba, Spain. earandaa@seom.org.
  • Aparicio J; Red Tematica de Investigación Cooperativa en Cancer (RTICC), ISCiii, Ministerio de Economía y Competitividad, Madrid, Spain. earandaa@seom.org.
  • Alonso V; Hospital Universitario y Politécnico La Fe, Valencia, Spain. japariciou@seom.org.
  • Garcia-Albeniz X; Red Tematica de Investigación Cooperativa en Cancer (RTICC), ISCiii, Ministerio de Economía y Competitividad, Madrid, Spain.
  • Garcia-Alfonso P; Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Salazar R; Harvard T.H. Chan School of Public Health, Boston, USA.
  • Valladares M; Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Vera R; Institut Català d'Oncologia (L'Hospitalet, Barcelona), Barcelona, Spain.
  • Vieitez JM; Complexo Hospitalario Universitario, A Coruña, Spain.
  • Garcia-Carbonero R; Complejo Hospitalario de Navarra, Pamplona, Spain.
Clin Transl Oncol ; 17(12): 972-81, 2015 Dec.
Article en En | MEDLINE | ID: mdl-26669312
ABSTRACT
Colorectal cancer (CRC) is the second leading cause of cancer dead in Spain. About half the patients will eventually develop distant metastases. However, as treatment options are expanding, prognosis has steadily improved over the last decades. Management of advanced CRC should be discussed within an experienced multidisciplinary team to select the most appropriate systemic treatment (chemotherapy and targeted agents) and to integrate surgical or ablative procedures when indicated. Disease site and extent, resectability, tumor biology and gene mutations, clinical presentation, patient preferences, and comorbidities are key factors to design a customized treatment plan. The aim of these guidelines is to provide synthetic recommendations for managing advanced CRC patients.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Guías de Práctica Clínica como Asunto Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Clin Transl Oncol Año: 2015 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Guías de Práctica Clínica como Asunto Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Clin Transl Oncol Año: 2015 Tipo del documento: Article País de afiliación: España